Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. IMD-1-0159
Published by: International Institute for Management Development (IMD)
Originally published in: 1997
Version: 08.12.2003
Length: 17 pages
Data source: Published sources

Abstract

After enjoying several decades of fast profit growth the pharmaceutical industry is under threat. Research and development costs are outstripping the return on investment, many of the best selling drugs are reaching the end of their 20 year patent protection period and there is the increasing threat of regulatory reform. Against this background Fisons plc (Fisons), a medium sized UK pharmaceutical company, is struggling. A new Chief Executive Officer is appointed. The third in three years. In his attempt to revive Fisons he is forced to adopt a radical programme of reform. His harsh medicine appears to be working when Fisons becomes the target of a hostile take-over bid from Rhone- Poulenc Rorer Inc (RPR), the giant French pharmaceutical company. Is Fisons able to fight off this bid and remain independent?
Location:
Industry:
Size:
GBP1,266 million turnover
Other setting(s):
1995

About

Abstract

After enjoying several decades of fast profit growth the pharmaceutical industry is under threat. Research and development costs are outstripping the return on investment, many of the best selling drugs are reaching the end of their 20 year patent protection period and there is the increasing threat of regulatory reform. Against this background Fisons plc (Fisons), a medium sized UK pharmaceutical company, is struggling. A new Chief Executive Officer is appointed. The third in three years. In his attempt to revive Fisons he is forced to adopt a radical programme of reform. His harsh medicine appears to be working when Fisons becomes the target of a hostile take-over bid from Rhone- Poulenc Rorer Inc (RPR), the giant French pharmaceutical company. Is Fisons able to fight off this bid and remain independent?

Settings

Location:
Industry:
Size:
GBP1,266 million turnover
Other setting(s):
1995

Related